Here are five things to know.
1. Allergan generated $4.33 billion in net revenue for the fourth quarter, marking a 12 percent increase from the same quarter a year prior.
2. This increase was largely driven by strong sales for Botox, which garnered $228.4 million in net revenue for the fourth quarter of fiscal year 2017.
3. Allergan reported total net revenues of $15.94 billion for fiscal year 2017 — a 9.4 percent increase from the previous fiscal year.
4. The drugmaker recorded $3.05 billion in net profit for the fourth quarter of 2017, according to Retuers.
5. Allergan also reported a $2.8 billion gain in the fourth quarter of 2017 due to the federal tax law enacted in December.
More articles on supply chain:
Celgene Executive Chairman Bob Hugin abruptly steps down: 5 things to know
As flu rages throughout Florida, Tamiflu supplies run low
Pfizer’s opioid-filled syringes hit another manufacturing snag: 6 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
